Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American native population

Genes and Immunity

Volumn 12, Issue 7, 2011, Pages 568-574

  El Gabalawy, H S ^a   Robinson, D B ^a   Daha, N A ^b   Oen, K G ^a   Smolik, I ^a   Elias, B ^a   Hart, D ^a   Bernstein, C N ^a   Sun, Y ^c   Lu, Y ^c   Houwing Duistermaat, J J ^b   Siminovitch, K A ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

genetic risk; immunogenetics; North American Native; rheumatoid arthritis

Indexed keywords

CYCLIN DEPENDENT KINASE 6; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HERPESVIRUS ENTRY MEDIATOR; HLA DR ANTIGEN; INTERLEUKIN 10; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; SECONDARY LYMPHOID TISSUE CHEMOKINE; STAT4 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; HLA SYSTEM; HUMAN; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ARTHRITIS, RHEUMATOID; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DRB1 CHAINS; HUMANS; INDIANS, NORTH AMERICAN; MALE; MODELS, GENETIC; NEPRILYSIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; TNF RECEPTOR-ASSOCIATED FACTOR 1;

EID: 80955181029     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.30     Document Type: Article

References (35)

1. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002; 4(Suppl 3): S265-S272.
2. Boyer GS, Templin DW, Lanier AP. Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1991; 18: 1477-1484.
3. Ferucci ED, Schumacher MC, Lanier AP, Murtaugh MA, Edwards S, Helzer LJ et al. Arthritis prevalence and associations in American Indian and Alaska Native people. Arthritis Rheum 2008; 59: 1128-1136.
4. Peschken CA, Esdaile JM. Rheumatic diseases in North America?s indigenous peoples. Semin Arthritis Rheum 1999; 28: 368-391. (Pubitemid 29289375)
5. Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol 2010; 22: 293-298.
6. Williams RC, Jacobsson LT, Knowler WC, del PA, Kostyu D, McAuley JE et al. Meta-analysis reveals association between most common class II haplotype in full-heritage Native Americans and rheumatoid arthritis. Hum Immunol 1995; 42: 90-94.
7. Oen K, El-Gabalawy HS, Canvin JM, Hitchon C, Chalmers IM, Schroeder M et al. HLA associations of seropositive rheumatoid arthritis in a Cree and Ojibway population. J Rheumatol 1998; 25: 2319-2323. (Pubitemid 28551846)
8. El-Gabalawy HS, Robinson DB, Hart D, Elias B, Markland J, Peschken CA et al. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol 2009; 36: 1130-1135.
9. Nelson JL, Boyer G, Templin D, Lanier A, Barrington R, Nisperos B et al. HLA antigens in Tlingit Indians with rheumatoid arthritis. Tissue Antigens 1992; 40: 57-63.
10. Templin DW, Boyer GS, Lanier AP, Nelson JL, Barrington RA, Hansen JA et al. Rheumatoid arthritis in Tlingit Indians: clinical characterization and HLA associations. J Rheumatol 1994; 21: 1238-1244. (Pubitemid 24234658)
11. Ferucci ED, Templin DW, Lanier AP. Rheumatoid arthritis in American Indians and Alaska Natives: a review of the literature. Semin Arthritis Rheum 2005; 34: 662-667. (Pubitemid 40193364)
12. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989; 36: 178-182. (Pubitemid 19218460)
13. Li Y, Begovich AB. Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis. Semin Immunol 2009; 21: 318-327.
14. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216-1223.
15. Lee HS, Korman BD, Le JM, Kastner DL, Remmers EF, Gregersen PK et al. Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum 2009; 60: 364-371.
16. Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K. Ethnic differences in allele frequency of autoimmune-diseaseassociated SNPs. J Hum Genet 2005; 50: 264-266. (Pubitemid 40922327)
17. Ikari K, Momohara S, Inoue E, Tomatsu T, Hara M, Yamanaka H et al. Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology (Oxford) 2006; 45: 1345-1348. (Pubitemid 44605467)
18. Barton A, Bowes J, Eyre S, Spreckley K, Hinks A, John S et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004; 50: 1117-1121. (Pubitemid 38480821)
19. Burr ML, Naseem H, Hinks A, Eyre S, Gibbons LJ, Bowes J et al. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis 2010; 69: 666-670.
20. Caponi L, Petit-Teixeira E, Sebbag M, Bongiorni F, Moscato S, Pratesi F et al. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis 2005; 64: 587-593. (Pubitemid 40469089)
21. Barnabe C, Elias B, Bartlett J, Roos L, Peschken C. Arthritis in aboriginal Manitobans: evidence for a high burden of disease. J Rheumatol 2008; 35: 1145-1150. (Pubitemid 351813164)
22. Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, van der Woude D et al. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 2008; 58: 3000-3008.
23. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, yre S, Thomson BP et al. Genome-wide association study metaanalysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508-514.
24. Perdigones N, Vigo AG, Lamas JR, Martinez A, Balsa A, Pascual-Salcedo D et al. Evidence of epistasis between TNFRSF14 and TNFRSF6B polymorphisms in patients with rheumatoid arthritis. Arthritis Rheum 2010; 62: 705-710.
25. Cheung TC, Oborne LM, Steinberg MW, Macauley MG, Fukuyama S, Sanjo H et al. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment. J Immunol 2009; 183: 7286-7296.
26. Kang YM, Kim SY, Kang JH, Han SW, Nam EJ, Kyung HS et al. LIGHT up-regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes. Arthritis Rheum 2007; 56: 1106-1117.
27. Pierer M, Brentano F, Rethage J, Wagner U, Hantzschel H, Gay RE et al. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 1063-1070. (Pubitemid 47050604)
28. Steinberg MW, Shui JW, Ware CF, Kronenberg M. Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners. Semin Immunopathol 2009; 31: 207-221.
29. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-1209. (Pubitemid 47443179)
30. Cordell HJ. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 2009; 10: 392-404.
31. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1 0401 MHC class II molecule. J Immunol 2003; 171: 538-541. (Pubitemid 36871358)
32. Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM et al. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 2008; 205: 967-979. (Pubitemid 351549891)
33. Oen K, Robinson DB, Nickerson P, Katz SJ, Cheang M, Peschken CA et al. Familial seropositive rheumatoid arthritis in North American Native families: effects of shared epitope and cytokine genotypes. J Rheumatol 2005; 32: 983-991. (Pubitemid 40828067)
34. Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, van der Helm-van Mil AH et al. Gene-gene and geneenvironment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007; 80: 867-875. (Pubitemid 46668455)
35. Cordell HJ. Epistasis: what it means, what it doesn?t mean, and statistical methods to detect it in humans. Hum Mol Genet 2002; 11: 2463-2468. (Pubitemid 35174710)